CN103566354B - 含有glp‑1类似物的衍生物或其可药用盐的药物组合物 - Google Patents
含有glp‑1类似物的衍生物或其可药用盐的药物组合物 Download PDFInfo
- Publication number
- CN103566354B CN103566354B CN201210258710.5A CN201210258710A CN103566354B CN 103566354 B CN103566354 B CN 103566354B CN 201210258710 A CN201210258710 A CN 201210258710A CN 103566354 B CN103566354 B CN 103566354B
- Authority
- CN
- China
- Prior art keywords
- glp
- weight
- ser
- pharmaceutical composition
- glu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210258710.5A CN103566354B (zh) | 2012-07-25 | 2012-07-25 | 含有glp‑1类似物的衍生物或其可药用盐的药物组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210258710.5A CN103566354B (zh) | 2012-07-25 | 2012-07-25 | 含有glp‑1类似物的衍生物或其可药用盐的药物组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103566354A CN103566354A (zh) | 2014-02-12 |
CN103566354B true CN103566354B (zh) | 2017-12-05 |
Family
ID=50039635
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210258710.5A Active CN103566354B (zh) | 2012-07-25 | 2012-07-25 | 含有glp‑1类似物的衍生物或其可药用盐的药物组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103566354B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3116271A1 (en) * | 2018-10-26 | 2020-04-30 | Novo Nordisk A/S | Stable semaglutide compositions and uses thereof |
JP2023524695A (ja) * | 2020-04-29 | 2023-06-13 | ノヴォ ノルディスク アー/エス | Glp-1作動薬およびヒスチジンを含む固形組成物 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101987868A (zh) * | 2009-07-30 | 2011-03-23 | 江苏豪森医药集团有限公司 | Glp-1类似物的衍生物或其可药用盐和用途 |
CN102233130A (zh) * | 2010-04-28 | 2011-11-09 | 江苏豪森药业股份有限公司 | 稳定的含有胸腺肽1衍生物的药物制剂 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6429197B1 (en) * | 1998-10-08 | 2002-08-06 | Bionebraska, Inc. | Metabolic intervention with GLP-1 or its biologically active analogues to improve the function of the ischemic and reperfused brain |
-
2012
- 2012-07-25 CN CN201210258710.5A patent/CN103566354B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101987868A (zh) * | 2009-07-30 | 2011-03-23 | 江苏豪森医药集团有限公司 | Glp-1类似物的衍生物或其可药用盐和用途 |
CN102233130A (zh) * | 2010-04-28 | 2011-11-09 | 江苏豪森药业股份有限公司 | 稳定的含有胸腺肽1衍生物的药物制剂 |
Non-Patent Citations (1)
Title |
---|
Long-acting glycagon-like peptide 1 receptor agonists;ALAN J.GARBER;《Diabetes care》;20110530;第34卷;5279-5284 * |
Also Published As
Publication number | Publication date |
---|---|
CN103566354A (zh) | 2014-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20220054594A1 (en) | Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2 | |
Aronoff et al. | Glucose metabolism and regulation: beyond insulin and glucagon | |
CN102421797B (zh) | Glp-1类似物的衍生物或其可药用盐和用途 | |
EP3010530B1 (en) | Insulin glargine/lixisenatide fixed ratio formulation | |
CN107249620B (zh) | 一种包含glp-1类似物的药物制剂及其制备方法 | |
CN102026641A (zh) | 并用或组合dpp-iv抑制剂和其它糖尿病治疗药的药品 | |
CN107636009A (zh) | 具有改善的稳定性的胰高血糖素衍生物 | |
Tharakan et al. | Emerging therapies in the treatment of ‘diabesity’: beyond GLP-1 | |
CN110267648A (zh) | 毒蜥外泌肽(9-39)的缓冲制剂 | |
CN106279400A (zh) | P8降糖肽的设计及其用途 | |
CN103987408A (zh) | 通过药理学靶向Kv1.3钾通道治疗肥胖和肥胖相关病症 | |
CN103566354B (zh) | 含有glp‑1类似物的衍生物或其可药用盐的药物组合物 | |
CN106519016A (zh) | 降糖调脂肽——Progly肽的设计及其用途 | |
CN103861089B (zh) | Glp-1类似物的衍生物或其可药用盐注射液及其制备方法和用途 | |
WO2019170153A1 (en) | GLP-1 Composition for Treating Obesity and Weight Management | |
Kadhe et al. | Advances in drug delivery of oral hypoglycemic agents | |
Chen et al. | An overview of hypoglycemic biological drugs | |
Argyrakopoulou et al. | DPP4 inhibitors: from sitagliptin monotherapy to the new alogliptin-pioglitazone combination therapy | |
CN104402990A (zh) | 一种用于治疗糖尿病的多肽 | |
CN113509544B (zh) | 一种具有降血糖作用的药物组合物 | |
Swetha et al. | A Comparative Review Of Drugs And Dosage Form Used In Diabetes Mellitus With Future Aspects | |
WO2018113340A1 (zh) | 多肽p11及其用途 | |
Kaku | Liraglutide for the treatment of diabetes mellitus in Japan | |
CN104262468B (zh) | 一种葡萄糖转运蛋白抑制多肽及其制备方法、应用 | |
Funnell | The therapeutic role of incretin mimetics and DPP-4 inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 222047 Lianyungang economic and Technological Development Zone, Jiangsu Applicant after: Jiangsu best Pharmaceutical Co.,Ltd. Address before: 222047 Lianyungang economic and Technological Development Zone, Jiangsu Applicant before: JIANGSU HANSOH PHARMACEUTICAL Co.,Ltd. Address after: 222047 Lianyungang economic and Technological Development Zone, Jiangsu Applicant after: JIANGSU HANSOH PHARMACEUTICAL GROUP Co.,Ltd. Address before: 222047 Lianyungang economic and Technological Development Zone, Jiangsu Applicant before: Jiangsu best Pharmaceutical Co.,Ltd. |
|
COR | Change of bibliographic data | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220808 Address after: 222047 No. 7 Kunlun Shan Road, Lianyungang economic and Technological Development Zone, Jiangsu Patentee after: JIANGSU HENGRUI MEDICINE Co.,Ltd. Address before: 222047 Lianyungang economic and Technological Development Zone, Jiangsu Patentee before: JIANGSU HANSOH PHARMACEUTICAL GROUP Co.,Ltd. |
|
TR01 | Transfer of patent right |